Medical devices, healthcare technology and the business of care
510(k) clearance · K261683

Augment Off-Axis Instrument System

Zimmer, Inc. · Decision date Jun 16, 2026

FDA DECISIONK261683

What did the FDA decide?

FDA records K261683 as a 510(k) premarket notification, with a decision dated Jun 16, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Jun 16, 2026

FDA source record

Regulatory record facts

Identifier
K261683
Regulatory pathway
510(k) premarket notification
Applicant
Zimmer, Inc.
Product code
PHX
Decision code
SESE
Decision date
Jun 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Shoulder Prosthesis, Reverse Configuration.

Applicant
Zimmer, Inc.
Product code
PHX
FDA device class
2

FDA decision timeline

  1. K261683 received

    Application receipt date recorded by FDA.

  2. K261683 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code PHX

Product / regulatory recordCompanyPathwayDecision dateSource
FX Shoulder Solutions, Inc.510(k) clearanceNov 5, 2026FDA
restor3d Inc.510(k) clearanceOct 22, 2026FDA
ENCORE MEDICAL, L.P.510(k) clearanceOct 2, 2026FDA
Restor3D510(k) clearanceJul 1, 2026FDA
Stryker Corporation (Tornier, Inc.)510(k) clearanceJun 12, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Zimmer, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Warsaw, IN

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records